Stay updated on Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition. The clinical trial page itself continues to display a 403 error.
    Difference
    1%
    Check dated 2026-10-24T16:19:43.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The site revision label in the footer changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T16:09:58.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.0 to v3.7.1; the page still displays a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T16:12:21.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The study page now renders a 403 Forbidden error, signaling that the page is temporarily inaccessible. The usual study details and navigation are replaced by the error screen.
    Difference
    19%
    Check dated 2026-09-19T20:50:17.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    New site revision label 'Revision: v3.6.6' has been added, replacing the previous 'Revision: v3.6.5'. This marks a software update on the page.
    Difference
    0.1%
    Check dated 2026-08-29T18:41:42.000Z thumbnail image
  6. Check
    80 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 has been added to the study record. The Plain Language Summary and the prior revision entry v3.6.4 have been removed, affecting lay reader readability and the revision history.
    Difference
    0.1%
    Check dated 2026-08-08T14:47:46.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page.